Q1 2025 Myomo Inc Earnings Call Transcript

May 7, 2025 / 08:30 PM GMT

Release Date Price: €4.14 (+0.98%)

Transcript 10-Q8-K

Key Points

Positve

Myomo Inc (MYO) reported a 162% increase in revenue for Q1 2025 compared to the prior year, driven by higher revenue units and average selling price.
The company successfully launched the MyoPro 2X, an upgraded version of its flagship device, reflecting its strategy of continuous innovation.
Medicare Part B patients represented 60% of revenue, highlighting successful penetration in this segment.
Myomo Inc (MYO) added a record 700 medically qualified candidates to its patient pipeline during Q1, ending the quarter with nearly 1,500 patients in the process of obtaining a MyoPro.
The international business, particularly in Germany, performed well, generating over $1.3 million in revenue, up 42% year over year.

Negative

The company faced challenges with lead generation due to changes in Meta's advertising policies, impacting the first half of Q1.
Medicare Advantage and certain commercial insurance plans continue to deny or delay authorizations, affecting the authorization rate.
The cost per pipeline ad increased by 31% year over year, impacting advertising efficiency.
The backlog decreased by 9% year over year, reflecting fewer pre-authorizations and a back-end loading of pipeline ads.
Operating expenses increased by 64% over the prior year, driven by higher headcount, advertising spend, and R&D expenses.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MYO.A - Myomo Inc
Q1 2025 Myomo Inc Earnings Call
May 07, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to the MyOO's first quarter 2025 earnings conference call. All participants will be in listen-only mode.

Should you need assistance, please signal a conference specialist by pressing the star key followed by 0.

After today's presentation, there will be an opportunity to ask questions.

Ask your question, you may press star, then one on a touchtone phone.

To withdraw your question, please press star, then 2. Please note this event is being recorded.

I would now like to turn the conference over to Turrith Patel. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-----------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.